|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0017431,
umls-concept:C0021747,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0079189,
umls-concept:C0087111,
umls-concept:C0229671,
umls-concept:C0441889,
umls-concept:C0524910,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2011-3-31
|
|
pubmed:abstractText |
We sought to clarify the associations among serum cytokines, amino acid substitutions in the interferon sensitivity-determining region (ISDR) and core region, and treatment outcome of pegylated interferon and ribavirin therapy in genotype 1 hepatitis C virus (HCV)-infected patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Core Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1537-6613
|
|
pubmed:author |
pubmed-author:IchijoTetsuyaT,
pubmed-author:JoshitaSatoruS,
pubmed-author:KamijoAtsushiA,
pubmed-author:KatsuyamaYoshihikoY,
pubmed-author:KomatsuMichiharuM,
pubmed-author:MarksP GPG,
pubmed-author:MatsumotoAkihiroA,
pubmed-author:Nagano Interferon Treatment Research Group,
pubmed-author:TanakaEijiE,
pubmed-author:UmemuraTakejiT,
pubmed-author:YonedaSuguruS,
pubmed-author:YoshizawaKanameK
|
|
pubmed:copyrightInfo |
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
203
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1087-95
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21398397-Amino Acid Substitution,
pubmed-meshheading:21398397-Antiviral Agents,
pubmed-meshheading:21398397-Biological Markers,
pubmed-meshheading:21398397-Cytokines,
pubmed-meshheading:21398397-Hepatitis C, Chronic,
pubmed-meshheading:21398397-Hepatitis C Antigens,
pubmed-meshheading:21398397-Humans,
pubmed-meshheading:21398397-Interferon-alpha,
pubmed-meshheading:21398397-Polyethylene Glycols,
pubmed-meshheading:21398397-Recombinant Proteins,
pubmed-meshheading:21398397-Ribavirin,
pubmed-meshheading:21398397-Sensitivity and Specificity,
pubmed-meshheading:21398397-Viral Core Proteins
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients.
|
|
pubmed:affiliation |
Department of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
